Antibiotics for Dogs: When Do They Help and What Should Owners Know?

Reading time: about 7 min

Why antibiotics are not a black-and-white issue

Antibiotics can save a dog’s life. At the same time, they can cause adverse effects, alter the gut microbiome and select for antibiotic-resistant bacteria. The right question is therefore not whether antibiotics are good or bad, but when they genuinely benefit an individual dog.

Not all inflammation is bacterial. Trauma, viruses, immune-mediated disease and tissue degeneration can also trigger inflammation. Antibiotics do not treat those underlying causes unless a bacterial infection is present as well. But when a serious bacterial infection is likely, delaying treatment may be more dangerous than starting before the final laboratory result is available.

Oscar’s story: decisions evolved during treatment

In March 2025, Oscar’s left front leg became very painful and swollen. By the time we reached the veterinarian on 25 March, he could not bear any weight on it. Investigations showed pre-existing chronic changes around the elbow joint and inflammation. His C-reactive protein (CRP) level was 58.3 mg/L. The veterinarians considered several possible causes. Initially, a neoplastic process was the main concern, but an inflammatory process also remained a possibility.

The attending veterinarians considered bacterial inflammation in the joint region to be one possible explanation. Oscar was started on Clavaseptin, containing amoxicillin and clavulanic acid, together with a short course of pain relief and anti-inflammatory medication. The next morning he cautiously began touching the ground with his toes. The painkillers were discontinued relatively soon, while Oscar continued to improve during antibiotic treatment. I regularly sent videos of his leg movements to the veterinarians, helping them assess his response to treatment.

Later, a fluid-filled blister appeared in the affected area. Bacterial culture of fluid collected from the blister grew Staphylococcus pseudintermedius, susceptible to Clavaseptin. This specimen came from an inflammatory lesion, not a superficial swab of healthy skin. The result supported the presence of a bacterial infection within the lesion, but did not prove on its own that the same bacterium caused the entire earlier problem around the joint. The culture result became available on 9 April. CRP had fallen to 29.6 mg/L by 4 April and to 5.3 mg/L by 14 April, when it was within the laboratory reference interval. Swelling diminished and Oscar increasingly used the leg.

Clavaseptin was initially prescribed for seven days and the course was subsequently extended twice. In other words, a course lasting several weeks was not decided in advance: the veterinarians adjusted treatment according to the clinical course, videos and test results. Recovery continued substantially longer than the antibiotic course itself. Oscar’s experience illustrates why an owner’s observations, a veterinarian’s clinical assessment and laboratory findings are more valuable together than any isolated measurement.

Empirical treatment, bacterial culture and susceptibility testing

Empirical antibiotic treatment means starting therapy before the final bacteriology results are available. It is not the same as prescribing antibiotics without justification ‘just in case’. The decision can be informed by the examination, severity of illness, inflammatory markers and a clinical suspicion of bacterial infection. When feasible, obtaining a sample before starting an antibiotic makes later interpretation easier; however, in urgent cases, sampling must not cause an unreasonable delay to necessary care.

Another important question is whether the dog needs an antibiotic that acts throughout the body at all. For many superficial bacterial skin infections, properly selected topical antiseptic treatment may be sufficient. The 2025 ISCAID guidance on canine skin infections recommends systemic antibiotics primarily for deep infections or when topical treatment is inadequate or impractical. This does not mean that a deep infection can be replaced by home skin care: treatment depends on the extent of the lesion and the dog’s condition.

Bacterial culture helps identify a microorganism. The result must always be interpreted in the context of where the sample was taken and the clinical signs, because Staphylococcus pseudintermedius, for example, may also inhabit normal canine skin. An antibiogram, or antimicrobial susceptibility test, indicates which drugs the isolated bacterium is susceptible to in the laboratory. It cannot guarantee treatment success by itself: the drug must also reach the infection site at an appropriate concentration, be dosed correctly and suit the dog’s overall health.

Antibiotic resistance: bacteria become resistant, not the dog

An antibiotic does not make the dog itself resistant. It changes the selection pressures on bacterial populations: susceptible bacteria decrease, while more resistant ones may gain an advantage. This can also affect the body’s normal microbiota, not only the disease-causing organism.

Studies in dogs have found an increased proportion of resistant intestinal bacteria after antibiotic treatment. Some changes may subside over time, so it would be wrong to claim that a single course inevitably causes a permanent problem. Nevertheless, repeated antibiotic courses are associated with a greater risk of finding resistant bacteria, including methicillin-resistant Staphylococcus pseudintermedius (MRSP). In recurrent infections, culture and susceptibility testing become particularly important.

How long should an antibiotic course last?

There is no universally correct treatment duration. For example, the ISCAID guidelines often recommend three to five days for sporadic bacterial cystitis and ten to fourteen days for pyelonephritis (kidney infection). Bacterial prostatitis may require weeks because delivering an antibiotic into prostate tissue is more difficult. Bone infections may also require longer treatment, sometimes combined with surgery.

You can learn more about urinary tract infections in FendaF’s article “Cystitis in Dogs”.

Small comparative studies of bacterial pneumonia in dogs suggest that some uncomplicated cases may recover with shorter treatment, but the certainty of the evidence remains limited. Results from one disease must not be automatically applied to another.

‘Always finish the course’ is useful advice to owners not to stop treatment on their own. A veterinarian, however, may shorten, extend or change treatment in response to new information. The aim is neither the shortest nor the longest possible course, but an adequate course without unnecessary additional exposure.

Side effects and drug interactions

Antibiotics may cause nausea, vomiting, diarrhoea and changes in appetite. Adverse effects depend on both the drug and the individual dog. Facial swelling, difficulty breathing or sudden weakness after a dose require immediate veterinary care. Severe or persistent diarrhoea, repeated vomiting or a marked deterioration in general condition should be discussed promptly with the treating veterinarian.

If a dog is also receiving anti-inflammatory pain medication, gastrointestinal side effects may overlap. That does not automatically make a particular antibiotic and anti-inflammatory medicine incompatible, but the entire treatment plan should be reviewed with the veterinarian. Supplements can affect drug absorption too. For example, minerals can reduce absorption of some tetracyclines. Doxycycline is less sensitive to calcium than certain older tetracyclines, so a blanket ban on all dairy foods for every regimen is unjustified. Follow the instructions for the specific preparation.

The microbiome and integrative support

Antibiotics can alter the intestinal bacterial community even when a dog does not develop diarrhoea. A microbiome change does not automatically equal disease, however, and the speed of recovery depends on the drug, the individual dog and other factors.

The value of a probiotic should be assessed according to its strain and intended purpose. Not all products are equivalent, and not every antibiotic course automatically requires a probiotic. Saccharomyces boulardii, for example, is a yeast, so ordinary antibacterial medicines do not directly destroy it in the same way they can destroy susceptible bacterial probiotics. That does not mean it is proven to be the best choice for every dog. Separating the administration times of a bacterial probiotic and an antibiotic may make sense for some products, but there is no universal two-hour rule. Follow the individual product’s directions. Clinical evidence for probiotics after antibiotics in dogs remains mixed.

Integrative veterinary medicine also considers the dog’s diet, appropriate dietary fibre and support for normal gastrointestinal function. These approaches have a plausible biological basis, but there is no one microbiome restoration protocol proven to work for every dog. Owners can monitor stool, appetite, energy and food tolerance, and discuss changes in diet or supplements with their veterinarian when needed. Antibiotic treatment and whole-body support are not opposites. In practice, support usually means continuing a familiar, well-tolerated, nutritionally complete diet, ensuring adequate fluid intake and, where appropriate, gradually introducing a fibre source after veterinary discussion. Adding several new supplements at once makes it harder to identify the cause of any adverse effects.

Recurrent infection: the same disease or a new problem?

When symptoms return, this does not automatically mean the previous course was too short. The problem may be a persistent infection, a relapse or a new infection. These possibilities call for different assessments. With recurrent cystitis, underlying predisposing factors deserve investigation. With recurring skin and ear infections, allergies or impaired skin-barrier function may contribute. For more detail about staphylococci, see FendaF’s article “Staphylococcus in Dogs: When Does a Normal Skin Bacterium Become a Problem?”.

Before another antibiotic course, it is worth asking what was learned from the previous treatment, whether a new culture is appropriate and whether an underlying cause remains that antibiotics alone cannot resolve. This is an area where a broader, including integrative, approach can add value without rejecting necessary antibacterial treatment.

How do you know whether the treatment worked?

No single measurement always provides the complete answer. CRP reflects a systemic inflammatory response but is not a test for the presence of bacteria. A downward trend alongside reduced swelling, pain and other symptoms supports the assessment that a dog is improving. Normal CRP does not exclude every localised infection, however; likewise, slowly resolving lameness does not by itself prove that active bacterial disease remains.

In Oscar’s case, the attending veterinarian explained that when there is no longer an active lesion from which a new sample can be taken, progress has to be assessed from the clinical picture. New swelling, heat, fever, sudden deterioration or a decline in general condition would justify reassessment. Recovery may continue after the infection itself has been brought under control.

What can a dog owner actually do?

Decisions about prescribing or changing the duration of an antibiotic course belong to the veterinarian. The owner’s role is nevertheless crucial: notice when symptoms begin, how they change, when improvement appears and whether side effects develop. A short diary or video can help the clinician follow the course of the illness.

Conclusion

Antibiotics are not the enemy, but they do not address the cause of every inflammatory condition. That is why they should not be used lightly. Their value ultimately depends on the right indication, an appropriate drug, adequate duration and attentive monitoring.

Support for a dog’s nutrition, microbiome and recovery can be part of the same approach.

In the end, we are not treating a laboratory result or an X-ray. We are treating an individual dog.

For a broader comparison of antibiotic benefits and risks, FendaF also has an article “Antibiotics: Pros and Cons” (in Estonian).

Sources

• Loeffler et al. (2025). ISCAID guidelines for canine pyoderma. https://pmc.ncbi.nlm.nih.gov/articles/PMC12058580/
• Weese et al. (2019). ISCAID guidelines on urinary tract infections. https://pubmed.ncbi.nlm.nih.gov/30971357/
• Lappin et al. (2017). ISCAID guidelines on respiratory infections. https://pmc.ncbi.nlm.nih.gov/articles/PMC5354050/
• Vientós-Plotts, Masseau and Reinero (2021). Comparative study of antibiotic therapy in canine pneumonia. https://pmc.ncbi.nlm.nih.gov/articles/PMC8614313/
• Reineke et al. (2024, online). Study of treatment duration in canine pneumonia. https://pubmed.ncbi.nlm.nih.gov/39305921/
• Systematic review and meta-analysis (2026). Antibiotic treatment of canine pneumonia. https://pubmed.ncbi.nlm.nih.gov/41547037/
• Schmidt et al. (2018). Antibiotic treatment and resistant E. coli in dog faeces. https://academic.oup.com/jac/article/73/12/3305/5095201
• Pilla et al. (2022). Antibiotics, intestinal microbiota and resistance in critically ill dogs. https://pmc.ncbi.nlm.nih.gov/articles/PMC9167539/
• Zur et al. (2016). Previous antibiotics and S. pseudintermedius resistance. https://pubmed.ncbi.nlm.nih.gov/27870236/
• Cornell University. Interpreting C-reactive protein (CRP) tests. https://www.vet.cornell.edu/animal-health-diagnostic-center/testing/testing-protocols-interpretations/c-reactive-protein

---

---